| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $217.0M | +62.0% |
| Cost of Revenue | $86.0M | +6.5% |
| Gross Profit | $131.0M | +146.2% |
| R&D Expense | $8.8M | +35.6% |
| SG&A Expense | $15.7M | +88.5% |
| Operating Income | $106.0M | +178.8% |
| Pre-tax Income | $110.3M | +213.0% |
| Income Tax | $27.5M | +200.4% |
| Net Income | $82.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $305.4M | +460.3% |
| Accounts Receivable | $2.9M | — |
| Current Assets | $325.8M | +384.6% |
| Total Assets | $347.7M | +288.8% |
| Current Liabilities | $84.4M | +49.7% |
| Total Liabilities | $93.6M | +26.6% |
| Stockholders' Equity | $254.2M | +1539.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | $153.6M | +2501.5% |
| +82.6% |
| EPS (Basic) | $0.99 | +125.0% |
| EPS (Diluted) | $0.99 | +125.0% |